Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.